Research ArticleVACCINES

A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain

See allHide authors and affiliations

Science Immunology  01 May 2020:
Vol. 5, Issue 47, eaba6466
DOI: 10.1126/sciimmunol.aba6466

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Immunology

Navigate This Article